Picture of National Instruments logo

NATI — National Instruments News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyBalancedLarge Cap

National Instruments Corp expected to post earnings of 58  cents a share - Earnings Preview

* National Instruments Corp  NATI.OQ   NATI.O  is expected
to show
a rise in quarterly revenue when it reports  results on July
27. 
    * The Austin Texas-based  company is expected to report  a
9.5% increase in revenue to $433.176 million from $395.52
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for National
Instruments Corp
is for earnings of 58 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for National
Instruments Corp is $60​, above​ its last closing price
of $56.35. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  0.54        0.54       0.62      Beat    14.3
 Dec. 31 2023  0.64        0.64       0.63      Missed  -0.9
 Sep. 30 2022  0.53        0.53       0.53      Met     0​
 Jun. 30 2022  0.11        0.17       0.36      Beat    118.2
 ​​Mar.        0.22        0.27       0.19      Missed  -30.3
 31 2022                                                
 Dec. 31 2021  0.19        0.20       0.30      Beat    52.5​
 Sep. 30 2021  0.18        0.18       0.20      Beat    11.1
 Jun. 30 2021  0.05        0.05       0.13      Beat    173.7
 This summary was machine generated July 25 at 22:08 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on National Instruments

See all news